Semaglutide use linked to lower COVID-19 and influenza severity with better renal outcomes after pandemic or seasonal infection
{{output}}
Respiratory viral infections continue to impose a large burden of hospitalization, organ failure and death, particularly among older adults and people with cardiometabolic disease. Whether prior semaglutide exposure is associated with lower post-infection seve... ...
